Neobiosis, LLC is a privately owned, clinical stage, biomedical contract development and manufacturing organization (CDMO) with two production facilities in downtown Gainesville and a Research & Development laboratory located within the Sid Martin UF Innovate biotechnology Institute in Alachua, FL. The focus of Neobiosis is the isolation of tissues, cells and extracellular vesicles (EVs), with medicinal potential, from donated perinatal (birth) tissues, including umbilical cord, umbilical cord blood and amniotic fluid. The name Neobiosis ("new life") is derived from a series of experiments called Parabiosis ("living together") where it was discovered that tissues, cells and EVs from a young donor could be used to promote the healing of older individuals. Neobiosis produces innovative products from healthy, full-term births, for client organizations who wish to take biomedical products though FDA-approved clinical trials for commercialization in a global market. Neobiosis is also committed to advancing an in-house pipeline of intellectual property and biologicals for use in anti-aging and regenerative medicine.
Company Details
- Employees
- 16
- Founded
- -
- Address
- Gainesville, Fl, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.neobiosis.com
- Keywords
- Regenerative Science and CDMO.
- HQ
- Gainesville, FL
Neobiosis Questions
Neobiosis's website is http://www.neobiosis.com
Neobiosis's LinkedIn profile is https://www.linkedin.com/company/neobiosis
Neobiosis has
16 employees.
View email and phone details for 16
employees at Neobiosis.
Neobiosis's industry is
Biotechnology Research
Neobiosis's top competitors are
Kincell Bio,
Nextgen™ Biologics, Inc.,
Mlm Biologics, Inc.,
Ways2well,
Lilium, Llc,
Neobiosys,
42bio, Inc.,
Reviverx,
10x Health System,
Space Aging Research Institute.
Neobiosis's categories are Biotechnology Research
Neobiosis's founding year is 2020
